Sodium Polystyrene Sulfonate Powder, For Suspension
Product Images NDC 46287-012

2 FDA label images from Cmp Pharma, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Sodium Polystyrene Sulfonate (NDC 46287-012). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cmp Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Sps 01)

Chemical Structure (Sps 01)
Chemical structure diagram of Sodium Polystyrene Sulfonate, showing the repeating unit composed of a benzene ring with attached sulfonate (SO3- Na+) group and ethylene (CH2-CH) side chain.*
FDA Label Image

Principal Display Panel (454 g Jar Label)

Principal Display Panel (454 g Jar Label)
Label for Sodium Polystyrene Sulfonate powder for suspension, 454 g, by CMP Pharma, Inc. The label includes the NDC 46287-012-16 and storage instructions to keep at 20°-25°C with permitted excursions. The product is indicated for oral or rectal use and is a prescription drug. A barcode and the CMP Pharma logo are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.